Is Oscar Health profitable in 2026?

Yes in Q1: Oscar reported net income of $679.0 million on May 6, 2026, its highest quarterly profit ever, reversing FY2025's $443.2 million net loss. It reaffirmed FY2026 guidance of $18.7 to 19.0 billion revenue and $250 to 450 million operating earnings, though later 2026 quarters are unconfirmed.

Who owns Oscar Health?

Oscar Health has traded publicly as NYSE: OSCR since its March 3, 2021 IPO, which raised about $1.4 billion. Thrive Capital, founded by co-founder Joshua Kushner, remains the largest shareholder per filings analyzed as of November 2024, with Vanguard holding roughly 6.9%.

Is Centene a bigger threat to Oscar Health than AI?

Yes. Centene's Ambetter brand already has greater ACA marketplace scale than Oscar, per a March 2026 competitive landscape analysis. Oscar calls itself the largest carrier fully dedicated to the individual market, but remains subscale against diversified insurers like UnitedHealth, Elevance, and CVS Aetna.

Could AI replace Oscar Health's insurance business?

No. Oscar's state licensure, CMS exchange integration, underwriting liability, and actuarial risk-adjustment data are regulatory moats AI cannot replicate. Its Oswell AI agent, launched November 2025, handles member triage and contributed to a 60 basis point SG&A improvement in Q1 2026, but it enhances rather than replaces the licensed insurer.

Did Oscar Health lay off staff?

Yes. Oscar announced a reduction in force in August 2025 alongside a cut FY2025 guidance following a Q2 2025 earnings miss, per Fierce Healthcare reporting dated August 6, 2025. Headcount has trended down modestly since 2023 even as revenue grew.

How has Oscar Health's stock performed in 2026?

Oscar's stock rose about 106% year to date, trading around $29.92 on July 20, 2026, up from $14.36 on January 1, 2026. That price sits above the roughly $20.78 average analyst consensus target reported mid-July 2026, reflecting divided Wall Street sentiment.

Insurance companies · United States

Oscar Health

hioscar.com ↗

Oscar Health sells ACA marketplace health plans using its own tech platform for claims and care.

Losing its protection

Assessed 20 July 2026 · Evidence as of 20 July 2026

The structural protection is eroding.

On the recordSince 20 July 2026 · Checkable from Aug 5-6, 2026 · Every call on the record Checkpoint: Q2 2026 earnings report tests if Q1 profit and 70.5% MLR hold as costs rise

The call

Oscar just posted a record quarter, but it still bets its whole business on a shrinking, subsidy-dependent ACA market against bigger, more diversified insurers.

Oscar Health is an insurance company that sells health plans mainly to people who buy coverage through the government's ACA marketplace. It is hard to replace because insurance requires state licenses, government approval, and relationships with doctors and hospitals that take years to build, but those same protections apply to every insurance company, including much larger rivals like Centene and UnitedHealth that sell many types of insurance and can absorb losses better when markets shrink. The one thing that matters most: whether Oscar can keep making money in the coming quarters as more people use medical care, and whether the number of customers buying ACA plans stays stable or keeps falling when government subsidies ended in early 2026.

Why

AI pressure: UnitedHealth's Optum AI-driven underwriting and claims engine. Bigger rivals use AI to price risk and cut claims costs faster, squeezing Oscar's margin edge on its own tech. Could AI do the core job? Unlikely.

Bigger players: Centene Corporation (Ambetter). Centene and other multiline carriers already sell more ACA plans and can absorb losses Oscar cannot. Could a giant copy it? Yes, easily.

What protects it. State insurance licenses, CMS risk-adjustment data, and provider contracts that took years to build.

What would change this call

Oscar's Q2 2026 earnings (~Aug 5-6, 2026) show MLR rising above 70.5% or missing $18.7-19.0B guidance. Would show Q1 profit was a seasonal spike, not durable improvement.
Fall 2026 ACA open-enrollment data shows Oscar membership flat or declining. Would confirm post-subsidy enrollment losses are hitting Oscar specifically, not just the market.
Centene, UnitedHealth, or CVS/Aetna publicly expand ACA marketplace footprint or pricing for 2027 plan year. Would show a diversified incumbent making a visible scale push into Oscar's core market.

Key numbers

FY2025 net loss $443.2 million (2026-02-10)
Q1 2026 net income $679.0 million (2026-05-06)
93% of premiums from ACA/CMS programs (2026-05-30)

Named risks

About 93% of premiums come from ACA marketplace, leaving Oscar exposed to a single policy cycle. Severity: high
National ACA enrollment fell 12% year over year after subsidy expiration on December 31, 2025. Severity: high
Pending litigation and CMS rulemaking on 2027 marketplace rules creates regulatory uncertainty through 2028. Severity: medium
Oscar had the highest ACA claim denial rate among national insurers in Plan Year 2024, at 25.3%. Severity: medium
Heavy insider stock selling with no offsetting buys reported in the three months to mid-July 2026. Severity: medium

Rivals, as read in July 2026

Rival	Direction	Evidence
Centene Corporation (Ambetter)	gaining on	Already larger ACA marketplace scale than Oscar per March 2026 competitive analysis
UnitedHealth Group	contesting	Far larger, diversified carrier with greater capacity to absorb medical-cost swings, noted May 2026
CVS Health/Aetna and Elevance Health	contesting	Deeper provider networks and multiline diversification versus Oscar's single-line ACA model
Hippocratic AI	contesting	Sells AI clinical agents directly to health systems, valued $3.5 billion as of November 2025, could commoditize Oscar's in-house AI tools

Questions people ask

Is Oscar Health profitable in 2026?: Yes in Q1: Oscar reported net income of $679.0 million on May 6, 2026, its highest quarterly profit ever, reversing FY2025's $443.2 million net loss. It reaffirmed FY2026 guidance of $18.7 to 19.0 billion revenue and $250 to 450 million operating earnings, though later 2026 quarters are unconfirmed.
Who owns Oscar Health?: Oscar Health has traded publicly as NYSE: OSCR since its March 3, 2021 IPO, which raised about $1.4 billion. Thrive Capital, founded by co-founder Joshua Kushner, remains the largest shareholder per filings analyzed as of November 2024, with Vanguard holding roughly 6.9%.
Is Centene a bigger threat to Oscar Health than AI?: Yes. Centene's Ambetter brand already has greater ACA marketplace scale than Oscar, per a March 2026 competitive landscape analysis. Oscar calls itself the largest carrier fully dedicated to the individual market, but remains subscale against diversified insurers like UnitedHealth, Elevance, and CVS Aetna.
Could AI replace Oscar Health's insurance business?: No. Oscar's state licensure, CMS exchange integration, underwriting liability, and actuarial risk-adjustment data are regulatory moats AI cannot replicate. Its Oswell AI agent, launched November 2025, handles member triage and contributed to a 60 basis point SG&A improvement in Q1 2026, but it enhances rather than replaces the licensed insurer.
Did Oscar Health lay off staff?: Yes. Oscar announced a reduction in force in August 2025 alongside a cut FY2025 guidance following a Q2 2025 earnings miss, per Fierce Healthcare reporting dated August 6, 2025. Headcount has trended down modestly since 2023 even as revenue grew.
How has Oscar Health's stock performed in 2026?: Oscar's stock rose about 106% year to date, trading around $29.92 on July 20, 2026, up from $14.36 on January 1, 2026. That price sits above the roughly $20.78 average analyst consensus target reported mid-July 2026, reflecting divided Wall Street sentiment.

Timeline

2026-07-16Federal judge halts eight CMS provisions reshaping 2027 ACA marketplace rules
2026-06-06Co-founder Mario Schlosser shifts from CTO to Co-Founder and Advisor to CEO
2026-05-06Q1 2026 results: record $679.0 million net income, MLR falls to 70.5%
2026-04-20Launches Lucie Health Marketplace, AI-powered multi-carrier shopping platform
2026-02-10FY2025 results: $11.7 billion revenue, $443.2 million net loss
2025-11-01Launches Oswell, an AI health agent for members
2025-10-20Expands 2026 open enrollment footprint to 573 counties across 20 states
2025-08-06Misses Q2 2025 estimates, announces layoffs and Hy-Vee ICHRA partnership
2021-03-03IPOs on NYSE, raising about $1.4 billion at $39 per share

Revision history

20 July 2026

First assessed. Losing its protection. The text above is fixed as of this date and is not edited afterwards.

In the same band

Centene Molina Healthcare Lincoln National